Skip to main content

NRDL Negotiation

Meaning

NRDL Negotiation refers to the highly structured, annual process where pharmaceutical manufacturers engage in price discussions with the National Healthcare Security Administration (NHSA) in China. The objective is to secure inclusion and determine the reimbursement level for their medications on the National Reimbursement Drug List (NRDL). For companies developing advanced hormonal therapies, successful negotiation is paramount as it unlocks massive market access and determines the drug’s effective patient affordability. This process is a crucial bridge between pharmaceutical innovation and public access.